Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer

There is a medical need to develop new and effective therapies against triple-negative breast cancer (TNBC). Chimeric antigen receptor (CAR) natural killer (NK) cells are a promising alternative to CAR-T cell therapy for cancer. A search for a suitable target in TNBC identified CD44v6, an adhesion m...

Descripción completa

Detalles Bibliográficos
Autores principales: Raftery, Martin J., Franzén, Alexander Sebastian, Radecke, Clarissa, Boulifa, Abdelhadi, Schönrich, Günther, Stintzing, Sebastian, Blohmer, Jens-Uwe, Pecher, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218876/
https://www.ncbi.nlm.nih.gov/pubmed/37240385
http://dx.doi.org/10.3390/ijms24109038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218876/
https://www.ncbi.nlm.nih.gov/pubmed/37240385
http://dx.doi.org/10.3390/ijms24109038

Ejemplares similares